|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$196,562,487 |
|
|
Indirect Value
|
$49,565,419 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$246,127,906 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-05-13 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,607,445 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-05-13 |
4 |
S |
$53.60 |
$3,763,828 |
D/D |
(70,000) |
1,537,445 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-05-28 |
4 |
OE |
$3.70 |
$44,409 |
D/D |
11,992 |
1,549,437 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-06-10 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,619,437 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-06-10 |
4 |
S |
$53.84 |
$3,778,785 |
D/D |
(70,000) |
1,549,437 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-07-08 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,620,229 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-07-08 |
4 |
S |
$52.69 |
$3,699,993 |
D/D |
(70,000) |
1,550,229 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-08-12 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,620,229 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-08-12 |
4 |
S |
$56.82 |
$3,977,729 |
D/D |
(70,000) |
1,550,229 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2008-12-22 |
4 |
OE |
$3.70 |
$99,970 |
D/D |
27,024 |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-01-13 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-01-13 |
4 |
S |
$49.05 |
$4,905,150 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-02-10 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-02-10 |
4 |
S |
$50.71 |
$5,087,073 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-10 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-10 |
4 |
S |
$44.07 |
$4,407,390 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
1,612,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-12 |
4 |
D |
$44.04 |
$705,257 |
D/D |
(16,014) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-14 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-14 |
4 |
S |
$46.28 |
$4,628,070 |
D/D |
(100,000) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-24 |
4 |
OE |
$3.65 |
$377,167 |
D/D |
103,376 |
1,699,615 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-24 |
4 |
S |
$45.92 |
$4,747,026 |
D/D |
(103,376) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-05-12 |
4 |
S |
$44.63 |
$4,463,320 |
D/D |
(100,000) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-05-12 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-06-09 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
367 Records found
|
|
Page 1 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|